{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nAlthough the query requested a summary for TMEM179, none of the provided abstracts describe any functions for a transmembrane protein with that designation. Instead, the supplied literature consistently profiles Polo‐like kinase 2 (PLK2, also known as SNK or serum‐inducible kinase) and its broad regulatory roles in normal physiology and disease. In several studies, PLK2 is shown to govern cell cycle progression and mitotic fidelity. Its expression in early G₁ and in developing tissues—as well as experiments demonstrating that PLK2 silencing or mutation increases apoptosis during spindle damage, delays S‐phase entry in fibroblasts, and disrupts mitotic spindle orientation in epithelial tissues—underscores a critical checkpoint function that prevents mitotic catastrophe and may contribute to tumor suppression. Furthermore, PLK2 activity is implicated in viral replication steps through its interaction with retroviral capsids, and careful assessment of PLK2 inhibition reveals that at effective target‐engaging doses the kinase does not promote genotoxic stress."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the nervous system, PLK2 orchestrates several key processes. It directly phosphorylates alpha‐synuclein at serine‐129—a modification commonly associated with Lewy body pathology—and, by coordinating the activity of Ras/Rap regulators, it modulates dendritic spine dynamics and synaptic plasticity, thereby affecting memory formation and neuronal stress responses. Studies using genetic knockdown, pharmacological inhibition, or knockout models reveal that perturbation of PLK2 reduces presynaptic phospho–alpha‐synuclein levels, dysregulates transcription of alpha‐synuclein, and even attenuates neuroinflammatory signaling mediated by phosphorylation of substrates such as HSP90α in activated microglia. Collectively, such findings position PLK2 as a pivotal mediator in diverse neurodegenerative contexts including Parkinson’s and Alzheimer’s diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its central roles in cell cycling and neuronal modulation, emerging evidence extends the functional repertoire of PLK2 to other tissue types. In vascular repair, for instance, modulation of the miR‐146a–PLK2 axis in progenitor cell populations appears critical for maintaining angiogenic capacity; PLK2 activity may also influence cardiac progenitor cell biology. Moreover, PLK2 loss or inhibition has been linked to fibrotic remodeling in the lung and to protective anti‐oxidative and anti‐inflammatory responses in kidney cells through phosphorylation of regulators like Nrf2. These diverse actions underscore the therapeutic potential of targeting PLK2 in conditions ranging from tumor progression and viral infections to neurodegeneration and tissue fibrosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Sheng Ma, Mei-Ann Liu, Yi-Lu O Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The serum-inducible protein kinase Snk is a G1 phase polo-like kinase that is inhibited by the calcium- and integrin-binding protein CIB."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12651910"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12651910"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Timothy F Burns, Peiwen Fei, Kimberly A Scata, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.23.16.5556-5571.2003"}], "href": "https://doi.org/10.1128/MCB.23.16.5556-5571.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12897130"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12897130"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Sheng Ma, Jean Charron, Raymond L Erikson "}, {"type": "b", "children": [{"type": "t", "text": "Role of Plk2 (Snk) in mouse development and cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.23.19.6936-6943.2003"}], "href": "https://doi.org/10.1128/MCB.23.19.6936-6943.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12972611"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12972611"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kent Fitzgerald, Marcelle Bergeron, Christopher Willits, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacological inhibition of polo like kinase 2 (PLK2) does not cause chromosomal damage or result in the formation of micronuclei."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Appl Pharmacol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.taap.2013.02.012"}], "href": "https://doi.org/10.1016/j.taap.2013.02.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23466428"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23466428"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Elizabeth Villegas, Elena B Kabotyanski, Amy N Shore, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plk2 regulates mitotic spindle orientation and mammary gland development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Development (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/dev.108258"}], "href": "https://doi.org/10.1242/dev.108258"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24598160"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24598160"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Irena Zurnic, Sylvia Hütter, Ute Rzeha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Pathog (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.ppat.1005860"}], "href": "https://doi.org/10.1371/journal.ppat.1005860"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27579920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27579920"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Kelly J Inglis, David Chereau, Elizabeth F Brigham, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.C800206200"}], "href": "https://doi.org/10.1074/jbc.C800206200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19004816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19004816"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Kea Joo Lee, Yeunkum Lee, Aaron Rozeboom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic structural plasticity, and memory."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuron (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuron.2011.02.004"}], "href": "https://doi.org/10.1016/j.neuron.2011.02.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21382555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21382555"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Heinrich Schell, Cindy Boden, André Maia Chagas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impaired c-Fos and polo-like kinase 2 induction in the limbic system of fear-conditioned α-synuclein transgenic mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0050245"}], "href": "https://doi.org/10.1371/journal.pone.0050245"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23209687"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23209687"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "M Bergeron, R Motter, P Tanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroscience (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuroscience.2013.09.061"}], "href": "https://doi.org/10.1016/j.neuroscience.2013.09.061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24128992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24128992"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Rikke H Kofoed, Jin Zheng, Nelson Ferreira, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2017.06.014"}], "href": "https://doi.org/10.1016/j.nbd.2017.06.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28648742"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28648742"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Ji Soo Lee, Yeunkum Lee, Emily A André, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of Polo-like kinase 2 ameliorates pathogenesis in Alzheimer's disease model mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0219691"}], "href": "https://doi.org/10.1371/journal.pone.0219691"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31306446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31306446"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Leah J Weston, Teresa L Stackhouse, Kateri J Spinelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2021.100273"}], "href": "https://doi.org/10.1016/j.jbc.2021.100273"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33428941"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33428941"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Junjie Cheng, Lei Wu, Xiaowan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polo-like kinase 2 promotes microglial activation via regulation of the HSP90α/IKKβ pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2024.114827"}], "href": "https://doi.org/10.1016/j.celrep.2024.114827"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39383034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39383034"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Shanming Deng, Huilan Wang, Chunling Jia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-146a Induces Lineage-Negative Bone Marrow Cell Apoptosis and Senescence by Targeting Polo-Like Kinase 2 Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.116.308378"}], "href": "https://doi.org/10.1161/ATVBAHA.116.308378"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27908889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27908889"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Michika Mochizuki, Vera Lorenz, Robert Ivanek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polo-Like Kinase 2 is Dynamically Regulated to Coordinate Proliferation and Early Lineage Specification Downstream of Yes-Associated Protein 1 in Cardiac Progenitor Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Heart Assoc (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/JAHA.117.005920"}], "href": "https://doi.org/10.1161/JAHA.117.005920"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29066438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29066438"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Theresa A Kant, Manja Newe, Luise Winter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cells (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cells10030617"}], "href": "https://doi.org/10.3390/cells10030617"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33799608"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33799608"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Da-Eun Kim, Hye Eun Byeon, Dae-Hoon Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "cip1"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " signaling in acute kidney injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Toxicol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10565-022-09741-1"}], "href": "https://doi.org/10.1007/s10565-022-09741-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35842499"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35842499"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jianfei Li, Feiju Ma "}, {"type": "b", "children": [{"type": "t", "text": "Polo-Like Kinase 2 Is Identified in Hypertrophy, Extracellular Matrix Accumulation, and Oxidative Stress of Mesangial Cells in Diabetic Nephropathy through p38-MAPK Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Clin Lab Sci (2023)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37094847"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37094847"}]}]}]}